has allergan gotten its groove back? let's find out with david pyott, the chairman of allergan.elcome back to "mad money." >> thanks for having me back, jim. let's start with the company's performance. it's performing really well right now. we had good top line growth, over 10%. on a non-gaap earnings per share basis, we have about 16% in the second quarter, year to date 17%. so everything's looking good. we exceeded guidance expected by wall street on almost every front. our markets are growing, and we had eight fda approvals since 2010 and about four more approvals on the horizon for the next year or so. short term, things look great. >> you said in the conference call we've got some challenges. one of these challenges is the drug restasis, that you may have some generic challenges. tell our viewers what you have in mind if things don't go allergan's way. >> absolutely. so let's first of all ground ourselves. restasis is the only approved drug in the united states for therapeutic dry eye, headed pretty rapidly towards $1 billion in sales, which makes it the largest non-retina

allergan says declassified several top secret documents detailing data collection and the discussion about surveillance tactics meanwhile taking center stage on capitol hill with lawmakers questioning the efficiency of such wide scale operations more now from washington and artie's correspondent liz wahl. well the leagues by edward snowden have led to a renewed national debate on government spying and privacy rights the revelations of the leaks prompted the senate judiciary committee to hold a hearing on five the foreign intelligence surveillance act that allows the government program to happen now f.b.i. and n.s.a. officials are in damage control mode eleven judges on the fars record are far from a rubber stamp instead they review all of our pleadings thoroughly question us and they don't approve an order until they are satisfied that we have met all statutory and constitutional requirements in an effort to appear more transparent director of national security james clapper has just released some documents from two thousand and nine to two thousand and eleven that were previously cl

sponsored by allergan.llergan. talk to your doctor about chronic migraine. 15 or more headache days a month each lasting 4 hours or more. it's proven to actually prevent headache days. and it's injected by a doctor once every 3 months. the effects of botox® (onabotulinumtoxina) may spread hours to weeks after injection causing serious symptoms. alert your doctor right away as difficulty swallowing speaking, breathing, eye problems, or muscle weakness can be a sign of a life-threatening condition. side effects may include allergic reactions neck and injection site pain fatigue, and headache. don't take botox® if you have a skin infection. tell your doctor about your medical history muscle or nerve conditions and medications, including botulinum toxins as these may increase the risk of serious side effects. the dose of botox® is not the same as other botulinum toxins. put the odds on your side. visit botoxchronicmigraine.com and talk to a headache specialist. >>> coming up on >> your realtime captioner: linda